Corpus Intelligence IC Memo — JENNIE STUART MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — JENNIE STUART MEDICAL CENTER
Investment Committee Memorandum | KY | 122 beds | Grade C | EBITDA uplift $12.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

JENNIE STUART MEDICAL CENTER

CCN 180051 | CHRISTIAN, KY | 122 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

JENNIE STUART MEDICAL CENTER is a 122-bed suburban community hospital in CHRISTIAN, KY with $165.3M in net patient revenue and a -6.1% operating margin. The hospital serves a payer mix of 31.4% Medicare, 2.0% Medicaid, and 66.7% commercial.

Thesis: Undervalued. Our ML models identify $12.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.1% to 1.3% (+736bps).

Net Revenue HCRIS$165.3M
Current EBITDA COMPUTED$-10.1M
Operating Margin COMPUTED-6.1%
Occupancy HCRIS38.7%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS27.8%
Distress Probability ML50.0%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
41
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -6.1% places it below the state median. Among 41 size-comparable peers (61-244 beds), the median margin is 1.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (61-244), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
JENNIE STUART MEDICAL CENTER (Target)KY122$165.3M-6.1%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
MERCY HEALTH LOURDES HOSPITAL KY178$288.1M7.7%
BAPTIST HEALTH CORBINKY197$285.4M1.4%
LAKE CUMBERLAND REGIONAL HOSPKY179$278.7M5.6%
BAPTIST HEALTH MADISONVILLEKY154$220.0M-5.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
EPHRAIM MCDOWELL REG MED CTRKY157$207.7M-13.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.5M+210bp18mo
Cost to Collect4.5%2.5%$3.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$106K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.5M
Cost to Collect
$3.3M
Denial Rate Reduction
$3.3M
A/R Days Reduction
$2.0M
Clean Claim Rate
$106K
Total EBITDA Uplift$12.2M
Current EBITDA$-10.1M
+ RCM Uplift+$12.2M
Pro Forma EBITDA$2.1M
Current Margin-6.1%
Pro Forma Margin1.3%
WC Released (1x)$6.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.5M$55.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.5M$55.7M0.00x-100.0%
Bull Case9.0x11.0x$-13.9M$90.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.9M$95.0M0.00x-100.0%
Bear Case11.0x10.0x$-17.0M$-586K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-17.0M$-6.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 61-244 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-9.6% / P50=1.4% / P75=10.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.